Mechanisms of Cutaneous Inflammation: Interactions Between Epidermal Cytokines, Adhesion Molecules, and Leukocytes

Archives of Dermatology

Volumn 125, Issue 10, 1989, Pages 1406-1412

  Kupper, Thomas S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

EDITORIAL; HUMAN; INFLAMMATION; PRIORITY JOURNAL; SKIN; T LYMPHOCYTE;

BIOLOGICAL FACTORS; CELL ADHESION MOLECULES; CYTOKINES; DERMATITIS; EPIDERMIS; HUMAN; KERATINOCYTES; T-LYMPHOCYTES;

EID: 0024456563     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1989.01670220102017     Document Type: Article

References (40)

1. Streilein JW. Lymphocyte traffic, T cell malignancies, and skin. J Invest Dermatol. 1978;71:167–171.
2. Edelson RL. Cutaneous T cell lymphoma: clues to a skin thymus interaction. J Invest Dermatol. 1976;67:419–424.
3. Dustin M, Singer K, Tuck D, Springer TA. Adherence of T lymphoblasts to epidermal keratinocytes is regulated by IFN gamma and mediated by ICAM-1. J Exp Med. 1988;167:1323–1340.
4. Shiohara T. Lichenoid tissue reaction: an immunological perspective. Am J Dermatopathol. 1988;10:252–256.
5. Griffiths C, Voorhees J, Nickoloff B, et al. Characterization of ICAM1 and HLA-DR expression in normal and inflamed skin. J Am Acad Dermatol. 1989;20:617–628.
6. Springer TA, Dustin M, Kishimoto T, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol. 1987;5:223–252.
7. Hogg N. The leukocyte integrins. Immunol Today. 1989;10:24–32.
8. Hynes RO. Integrins: a family of cell surface receptors. Cell. 1987;48:549–554.
9. Nickoloff BJ. The role of IFN gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular events. Arch Dermatol. 1988;124:1835–1843.
10. Marlin SD, Springer T. Purified ICAM-1 is a ligand for LFA-1. Cell. 1987;51:813–819.
11. Lange-Wantzin G, Ralfkiaer E, Avstorp C, et al. Kinetics and characterization of ICAM-1 expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J Am Acad Dermatol. In press.
12. Nickoloff BJ, Griffiths C, Baadsgaard O, et al. Markedly diminished epidermal keratinocyte expression of ICAM-1 in Sézarysyndrome. JAMA. 1989;261:2217–2221.
13. Sackstein R, Falanga V, Streilein JW, Chin YH. Lymphocyte adhesion to psoriatic dermal epithelium is mediated by a tissue specific receptor/ligand interaction. J Invest Dermatol. 1988; 91:423–428.
14. Bierer B, Burakoff SJ. T cell adhesion molecules. FASEB J. 1988;2584–2590.
15. Altman DM, Hogg N, Trowsdale J, Wilkinson D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature. 1989;338:513–514.
16. Clayberger CL, Medeiros LJ, Link P, et al. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet. 1987;2:533.
17. Gregory C, Murray R, Edwards C, Rickinson A. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus positive Burkitt's lymphoma underlies tumor cell escape from virus specific T cell surveillance. J Exp Med. 1988;167:1811–1824.
18. Greve J, Davis G, Meyer A, et al. The major rhinovirus receptor is ICAM-1. Cell. 1989;56:839–847.
19. Staunton D, Merluzzi V, Rothlein et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989;56:849–853.
20. Anderson DC, Springer TA. Leukocyte adhesion deficiency. Annu Rev Med. 1987;38:175–194.
21. Sanchez-Madrid F, Nagy JA, Robbins E, et al. Characterization of a human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit: the lymphocyte function associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the P150,95 molecule. J Exp Med. 1983;158:1785–1803.
22. Anderson D, Schmalstieg F, Finegold M, et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: the quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis. 1985;152:668–689.
23. Kupper TS. Interleukin 1 and other immunologically active cytokines produced by human keratinocytes: functional and molecular characterization. Adv Dermatol. 1988;3:293–307.
24. Kupper TS. Hematopoietic, lymphopoieitic, and proinflammatory cytokines produced by keratinocytes. Ann NY Acad Sci. 1988;548:262–270.
25. Kupper TS. Production of cytokines by epithelial tissues: a new model for cutaneous inflammation. Am J Dermatopathol. 1989;11:69–73.
26. Dustin M, Rothlein R, Bhan K, Dinarello LA, Springer TA. Induction by IL-1 and IFN, tissue distribution, biochemistry, and function of ICAM-1. J Immunol. 1986;137:245–254.
27. Poo W, Conrad L, Janeway CJ Jr. Receptor-directed focusing of lymphokine release by T-helper cells. Nature. 1988;332:378–380.
28. Mizutani H, Rothlein R, Mainolfi L, Kupper TS. Effects of PUVA on the binding of T-cell LFA-1 to epithelial cell ICAM-1 and the autologous expression of T-cell ICAM-1: potential therapeutic mechanisms in epidermotropic T-cell diseases. Clin Res. 1989; 37:353.
29. Lisby S, Ralfkiaer E, Rothlein R, Vejlsgaard GL. Intercellular adhesion molecule-1 (ICAM-1) expression correlated to inflammation. Br J Dermatol. 1989;120:479–484.
30. Abstracts of the ESDR-JSID-SID Tricontinental Meeting. J Invest Dermatol. 1989;92:393–548.
31. Kupper TS. The role of epidermal cytokines. In: Oppenheim J, Shevach E, eds. The Immunophysiology of Cells and Cytokines. New York, NY: Oxford University Press. In press.
32. Kupper T, Lee F, Birchall N, Clark S, Dower SK. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony stimulating factor mRNA and protein: a potential autocrine role for interleukin 1 in epidermis. J Clin Invest. 1988;82:1787–1792.
33. Blanton B, Kupper TS, McDougall J, Dower S. Regulation of interleukin 1 and its receptor on human keratinocytes. Proc Natl Acad Sci USA. 1989;86:1273–1277.
34. Curtis B, Gallis B, Overell R, et al. T cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to IL-1. Proc Natl Acad Sci USA. 1989; 86:3045–3049.
35. Grossman R, Gottlieb A, Sehgal P, et al. Increased IL-6 in psoriatic plaques. J Invest Dermatol. 1989;92:437.
36. Ashworth J, Turner M, Hitch G, et al. Epidermal cytokine mRNA expression in lesional and uninvolved skin in psoriasis vulgaris. J Invest Dermatol. 1989;92:397.
37. Hammerberg C, Fisher G, Baadsgaard O, et al. Characterization of IL-1 and inhibitor in psoriatic and normal skin. J Invest Dermatol. 1989;92:439.
38. Sauder DN, Monick M, Hunninghake G. Epidermal cell derived thymocyte activating factor is a potent T cell chemoattractant. J Invest Dermatol. 1986;85:431–437.
39. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 1989;243:1464–1466.
40. Larsen C, Oppenheim J, Matsushima K. Interleukin 1 or tumor necrosis factor stimulate the production of neutrophil activating protein by normal human fibroblasts and keratinocytes J Invest Dermatol. 1989;92:467.